Literature DB >> 19344304

Gliomas in patients with neurofibromatosis type 1.

Anne C Albers1, David H Gutmann.   

Abstract

Neurofibromatosis type 1 (NF1) is an inherited autosomal dominant disorder characterized by numerous cutaneous features, including café-au-lait macules, skinfold freckling and iris hamartomas. In addition, individuals with NF1 are prone to the development of both benign and malignant tumors. The most common CNS tumor in children and adults with NF1 is the glioma. In childhood, gliomas are primarily located in the optic pathway, and less frequently in the hypothalamus and brainstem. Regular ophthalmologic evaluations in children are essential for the effective management of these tumors in patients with NF1. Adults, in contrast, are more likely to develop higher grade gliomas, which are treated in a similar fashion as their sporadic counterparts.

Entities:  

Mesh:

Year:  2009        PMID: 19344304     DOI: 10.1586/ern.09.4

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  21 in total

Review 1.  Neuroimaging of phakomatoses: overview and advances.

Authors:  Gilbert Vézina
Journal:  Pediatr Radiol       Date:  2015-09-07

2.  Cerebellar Hypoplasia and Dysmorphia in Neurofibromatosis Type 1.

Authors:  Sandra P Toelle; Andrea Poretti; Peter Weber; Tatjana Seute; Jacoline E C Bromberg; Ianina Scheer; Eugen Boltshauser
Journal:  Cerebellum       Date:  2015-12       Impact factor: 3.847

3.  Usefulness of (18)F-FDG-PET/CT in Evaluating a Brainstem Glioma in an Adult Patient with Neurofibromatosis Type 1.

Authors:  Giorgio Treglia; Barbara Muoio; Annemilia Del Ciello; Francesco Bertagna
Journal:  Nucl Med Mol Imaging       Date:  2013-02-07

4.  Peri-gestational risk factors for pediatric brain tumors in Neurofibromatosis Type 1.

Authors:  Kimberly J Johnson; Nancy L Zoellner; David H Gutmann
Journal:  Cancer Epidemiol       Date:  2016-03-25       Impact factor: 2.984

Review 5.  Therapeutic advances for the tumors associated with neurofibromatosis type 1, type 2, and schwannomatosis.

Authors:  Jaishri O Blakeley; Scott R Plotkin
Journal:  Neuro Oncol       Date:  2016-02-06       Impact factor: 12.300

6.  Surveillance magnetic resonance imaging for isolated optic pathway gliomas: is gadolinium necessary?

Authors:  Ezekiel Maloney; A Luana Stanescu; Francisco A Perez; Ramesh S Iyer; Randolph K Otto; Sarah Leary; Lotte Steuten; Amanda I Phipps; Dennis W W Shaw
Journal:  Pediatr Radiol       Date:  2018-05-22

7.  Racial/Ethnic Differences in Pediatric Brain Tumor Diagnoses in Patients with Neurofibromatosis Type 1.

Authors:  Salmafatima S Abadin; Nancy L Zoellner; Melody Schaeffer; Bree Porcelli; David H Gutmann; Kimberly J Johnson
Journal:  J Pediatr       Date:  2015-05-28       Impact factor: 4.406

8.  Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomas.

Authors:  Matthias A Karajannis; Geneviève Legault; Michael J Fisher; Sarah S Milla; Kenneth J Cohen; Jeffrey H Wisoff; David H Harter; Judith D Goldberg; Tsivia Hochman; Amanda Merkelson; Michael C Bloom; Angela J Sievert; Adam C Resnick; Girish Dhall; David T W Jones; Andrey Korshunov; Stefan M Pfister; Charles G Eberhart; David Zagzag; Jeffrey C Allen
Journal:  Neuro Oncol       Date:  2014-05-06       Impact factor: 12.300

9.  Associations between allergic conditions and pediatric brain tumors in Neurofibromatosis type 1.

Authors:  Bree Porcelli; Nancy L Zoellner; Salmafatima S Abadin; David H Gutmann; Kimberly J Johnson
Journal:  Fam Cancer       Date:  2016-04       Impact factor: 2.375

10.  BET bromodomain inhibition triggers apoptosis of NF1-associated malignant peripheral nerve sheath tumors through Bim induction.

Authors:  Amish J Patel; Chung-Ping Liao; Zhiguo Chen; Chiachi Liu; Yong Wang; Lu Q Le
Journal:  Cell Rep       Date:  2013-12-27       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.